After the surprise departure of…
After the surprise departure of longtime CEO Lars Fruergaard Jørgensen [...]
A PD-L1xVEGF bispecific antibody…
A PD-L1xVEGF bispecific antibody from China’s ImmuneOnco Biopharmaceuticals has shown [...]
AbbVie is ending development of an…
AbbVie is ending development of an IL-1 asset as a [...]
Nuvectis Pharma has dropped plans…
Nuvectis Pharma has dropped plans to develop NXP800 in ovarian [...]
Frazier Life Sciences has gathered…
Frazier Life Sciences has gathered an impressive $1.3 billion in [...]
The FDA has missed the date for…
The FDA has missed the date for Coya Therapeutics’ investigational [...]
Weeks after the biotech gave up on…
Weeks after the biotech gave up on a psoriasis trial [...]
Cardiff Oncology has reported…
Cardiff Oncology has reported updated results from its phase 2 [...]
As Merck & Co. rolls out a…
As Merck & Co. rolls out a widespread cost-cutting initiative, [...]
Quoin Pharmaceuticals has ended…
Quoin Pharmaceuticals has ended development of two programs, pulling back [...]